Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention

Description

This research study is evaluating an educational intervention for women who have experienced changes in sexual function after treatment for ovarian cancer.

Study Start Date

November 2014

Estimated Completion Date

October 2019

Interventions

  • Behavioral: Webinar
  • Behavioral: Telephone Coaching Session
  • Behavioral: Group Session

Specialties

  • Obstetrics & Gynecology: Gynecologic Oncology
  • Oncology: Gynecologic Oncology
  • Physician Assistant: Hematology/Oncology,Obstetrics/Gynecology

MeSH Terms

  • Ovarian Cancer
  • Ovarian Neoplasms

Study ID

Dana-Farber Cancer Institute -- 14-368

Status

Unknown

Trial ID

NCT02287519

Study Type

Interventional

Trial Phase

N/A

Enrollment Quota

75

Sponsor

Dana-Farber Cancer Institute

Inclusion Criteria

  • Women diagnosed with Stage1-IV ovarian cancer
  • Prognosis of at least one year to live (as assessed by provider)
  • Endorsement of at least one sexual symptom (see Appendix A for eligibility screening)
  • English speaking
  • Signed informed consent

Exclusion Criteria

  • History of pelvic radiation
  • Cognitive impairment which would interfere with the ability to participate in the study (as assessed by provider)

Gender

Female

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (2)

Study Location Distance Name Phone Email
Dana Farber Cancer Institute - Boston, Massachusetts 2.6 miles Sharon Bober PhD 617-632-6547 sharon_bober@dfci.harvard.edu
Massachusetts General Hospital - Boston, Massachusetts 2.8 miles Carolyn Krasner MD 617-726-1941 pdicicco@partners.org

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.